• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC. MOSAIC ULTRA; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC. MOSAIC ULTRA; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 305
Device Problem Break (1069)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/09/2018
Event Type  malfunction  
Event Description
While suturing a valve into position, a suture broke when tied, which then caused concerns that it may or may not cause it to function properly, thus this one was removed and a new valve was placed into position.The valve was then sized for a 23 mm medtronic mosaic ultra aortic tissue valve.The sutures were placed.The valve was then seated and the sutures were tied.One of the valve sutures broke at this point and it was not possible to place extra sutures.The valve had to be removed and all pledgets taken out.It was decided to enlarge the aortic root because the 23 mm aortic valve was very tight.The aortotomy incision was carried down toward the commissure between the left coronary and the noncoronary cusp.The commissure was divided, and the incision carried down toward the anterior leaflet of the mitral valve.A 34 mm hemashield patch was obtained and a patch was cut from the graft to be used for the enlargement.The aortic root was then enlarged using 4-0 prolene suture and then a 5-0 prolene suture as a second layer.A new 23 mm medtronic mosaic ultra valve was obtained because i was not sure whether the old valve was damaged during the removal.The valve sutures were placed.The valve was then seated and the sutures were tied.The patient was then rewarmed.The aortotomy incision was then closed using the hemashield patch and 4-0 prolene running sutures followed by 5-0 prolene running sutures.Before the complete closure of the aortotomy as much of the air was evacuated from the left heart as possible and once the aortotomy incision was closed, the crossclamp was then removed while aspirating the air out of the ascending aorta.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIC ULTRA
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC, INC.
1851 east deere ave.
santa ana CA 92705
MDR Report Key9738874
MDR Text Key180398038
Report Number9738874
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Reporter Occupation Risk Manager
Type of Report Initial
Report Date 01/15/2020,01/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/21/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number305
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/15/2020
Device Age0 YR
Event Location Hospital
Date Report to Manufacturer02/21/2020
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age24090 DA
Patient Weight76
-
-